GMED250117P115000
- 0.00
- 0.000.00%
Globus Medical Newsroom
Barclays Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $100
Barclays Keeps Their Buy Rating on Globus Medical (GMED)
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $91
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $100 to $115
Globus Medical Is Maintained at Buy by Canaccord Genuity
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $90 to $115
Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Reviva Pharmaceuticals Holdings (RVPH)
Globus Medical Analyst Ratings
Needham Maintains Globus Medical(GMED.US) With Hold Rating
Needham Keeps Their Hold Rating on Globus Medical (GMED)
Wells Fargo Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $95
Positive Outlook and Buy Rating for Globus Medical Amid Strong Sales and Market Confidence
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $91
BTIG Sticks to Their Buy Rating for Globus Medical (GMED)
RBC Capital Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $101
RBC Capital Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $101
Piper Sandler Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $100
Piper Sandler Reaffirms Their Buy Rating on Globus Medical (GMED)
Truist Financial Maintains Globus Medical(GMED.US) With Hold Rating, Raises Target Price to $90
Roth MKM Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $115